Clinical Applications

The company’s diagnostic products will be used in physicians’ practices for diagnosing cardiovascular disease and for monitoring of the effectiveness of cardiovascular therapies. Angiologix’ products will identify patients, whose early-stage cardiovascular disease is undetected by the existing diagnostic methods, and direct their physicians to prescribe cardiovascular therapies at the time when such interventions are most effective. Such therapies include some of the marketed statins and ACE-inhibitors which have been shown to reverse endothelial dysfunction. The reversal of endothelial dysfunction is a crucial indicator of the effectiveness of cardiovascular therapies. The monitoring of endothelial dysfunction in patients receiving such therapies will allow physicians to select the most effective regimens.